## Abstract The plasminogen activator levels of a series of murine tumors commonly used in cancer drug screening were determined and compared to the levels found in normal mouse tissues. Tumors high in plasminogen activator included the B16 and colon 26. The Lewis lung and M5076 carcinoma showed an
Distribution and survival of passively transferred lymphoblasts in normal and tumor-bearing mice
โ Scribed by S. J. Normann; J. Cornelius
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 742 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Although most circulating lymphocytes are long-lived small lymphocytes, it is the recently-divided medium and large-sized lymphoblasts that most clearly migrate to sites of inflammation, and they do so without regard to immunologic commitment. The tumor-bearing state frequently suppresses macrophage accumulation at inflammatory sites but it is not known whether lymphocyte traffic is similarly affected. We addressed this issue using passively transferred radiolabelled lymphoblasts. Lymphoblasts readily entered s.c. fibrosarcomas transplanted to C57BL/6 mice. Large and small tumors acquired the same number of lymphoblasts per gram of tumor, indicating the absence of an anti-inflammatory reaction. However, the intra-tumoral survival of lymphoblasts was shorter in large than in small tumors. Shortened survival was noted also in spleen and whole body of animals bearing tumors. Shortened survival rather than impaired emigration may contribute to the increase in tumor:lymphocyte ratio observed with large tumors. The adverse effect of tumor bearing on lymphoblast survival may be limited to tumors which acquire a high percentage of passively transferred lymphocytes since intraperitoneal P-815 mastocytomas in DBA/2 mice acquired few labelled lymphoblasts and did not alter lymphoblast survival. These results are important for host resistance to tumor growth and therapeutically for the use of lymphocyte cytotoxic cells induced to proliferate in vitro.
๐ SIMILAR VOLUMES
## Abstract Quantitative immunofluorescence tests were used to study MTVโantigen production in normal and mammary tumorโbearing mice of two low (BALB/c and C3Hf) and two high (C3H and GR) mammary cancer strains. Mammary tumors could be distinguished on the basis of MTVโantigen expression in two gro
## Abstract The effect of serum from mice bearing methylcholanthreneโinduced fibrosarcomas on the lymphoproliferative responses of their spleen and lymphnode cells to 3 M KCIโsolubilized tumor antigens has been investigated. Low concentrations of serum (โค2.5%) collected throughout the course of tum
Tirapazamine, a new bioreductive agent currently advancing through clinical trials, may have a valuable role to play in cancer therapy. In vitro, the drug shows markedly more toxicity to hypoxic cells than to aerobic cells, and preferential activity against hypoxic cells of solid tumors in vivo also
## Abstract Evolution of virus expression in different lymphoid organs as well as in solid syngeneic tumors of mice inoculated with an MuLV was studied with the aid of __in vitro__ XC coโculture technique. When normal adult mice of strain XLII were inoculated intraperitoneally with a cultured Rausc
Bacillus Calmette-Guirin (BCG) was administered in various doses by four different routes to C3H/HeJ mice bearing wellestablished syngeneic MC-42 fibrosarcomas. Injections of BCG into established primary tumors decreased survival of tumor-bearing mice as compared to saline-injected controls. Of the